History and exam

Key diagnostic factors

common

presence of risk factors

Risk factors include: history of depression, obsessive-compulsive disorder, chronic pain, attention deficit hyperactivity disorders.

change in mental status

If a patient has reduced consciousness, monitor for respiratory depression as intubation may be necessary.[11]

tachycardia

Sinus tachycardia is the most common rhythm in tricyclic antidepressant overdose. Wide complex tachycardia occurs in severe overdose. Its absence makes the diagnosis of severe poisoning unlikely.

hypotension

As a result of alpha-1 antagonism, hypotension is quite common.[4]

mydriasis

Dilated pupils are part of the anticholinergic toxidrome.

Do not use physostigmine to reverse anticholinergic signs caused by tricyclic antidepressant overdose because, in rare cases, it has been associated with causing asystole.[20]

Absence of anticholinergic toxidrome makes the diagnosis unlikely, although cardiovascular effects can be so prominent that these anticholinergic manifestations may be overlooked.

warm, dry, flushed skin

Part of the anticholinergic toxidrome.

Do not use physostigmine to reverse anticholinergic signs caused by tricyclic antidepressant overdose because, in rare cases, it has been associated with causing asystole.[20]

Absence of anticholinergic toxidrome makes the diagnosis unlikely, although cardiovascular effects can be so prominent that these anticholinergic manifestations may be overlooked.

change in mental status

Changes in mental status, varying from slight drowsiness to delirium or coma, are part of the anticholinergic toxidrome.

Do not use physostigmine to reverse anticholinergic signs caused by tricyclic antidepressant overdose because, in rare cases, it has been associated with causing asystole.[20]

Absence of anticholinergic toxidrome makes the diagnosis unlikely, although cardiovascular effects can be so prominent that these anticholinergic manifestations may be overlooked.

decreased or absent bowel sounds

Part of the anticholinergic toxidrome.

Do not use physostigmine to reverse anticholinergic signs caused by tricyclic antidepressant overdose because, in rare cases, it has been associated with causing asystole.[20]

Absence of anticholinergic toxidrome makes the diagnosis unlikely, although cardiovascular effects can be so prominent that these anticholinergic manifestations may be overlooked.

urinary retention

Part of the anticholinergic toxidrome.

Do not use physostigmine to reverse anticholinergic signs caused by tricyclic antidepressant overdose because, in rare cases, it has been associated with causing asystole.[20]

Absence of anticholinergic toxidrome makes the diagnosis unlikely, although cardiovascular effects can be so prominent that these anticholinergic manifestations may be overlooked.

ophthalmic signs

Divergent squint, internuclear ophthalmoplegia and gaze paralysis; nystagmus may also be seen.

neurological signs

Ataxia, and myoclonic and choreoathetoid movements, may be seen. Increased muscle tone, hyperreflexia, and extensor plantar responses may occur.

Other diagnostic factors

common

features of serotonin syndrome

The clinical features of serotonin syndrome include hyperpyrexia, impaired consciousness level or agitation, increased muscle tone, and clonus. It is often associated with an elevated creatine kinase level.[13] Features of serotonin toxicity may also occur if the patient has co-ingested other drugs that increase the effect of serotonin, or is taking one of these drugs therapeutically. These include: selective serotonin reuptake inhibitors, venlafaxine, monoamine oxidase inhibitors, amfetamines, cocaine, MDMA (ecstasy), linezolid, tramadol, or triptans. 

Risk factors

strong

history of depression

Despite their use for other conditions, a history of depression is still the most likely reason for tricyclic antidepressant overdose.[15] Depression may lead to suicidality and must be assessed with the Scale for Suicide Ideation by Beck et al.[16]

obsessive-compulsive disorder

May lead to tricyclic antidepressant (TCA) overdose. Risk of overdose is related to the use of TCAs prescribed for the disease, rather than the underlying disease itself.

chronic pain

May lead to tricyclic antidepressant (TCA) overdose. Risk of overdose is related to the use of TCAs prescribed for the disease, rather than the underlying disease itself.

attention deficit hyperactivity disorders

May lead to tricyclic antidepressant (TCA) overdose. Risk of overdose is related to the use of TCAs prescribed for the disease, rather than the underlying disease itself.

Use of this content is subject to our disclaimer